申请人:Eisai Co., Ltd.
公开号:EP1116716A1
公开(公告)日:2001-07-18
A cyclic amine compound or a salt thereof is defined by the formula:
in which J is
(a) an optionally substituted group selected from (1) phenyl, (2) pyridyl, (3) pyrazyl, (4) quinolyl, (5) cyclohexyl, (6) quinoxalyl and (7) furyl;
(b) a monovalent or divalent group, in which the phenyl may have a substituent(s) selected from the group consisting of (1) indanyl, (2) indanonyl, (3) indenyl, (4) indenonyl, (5) indanedionyl, (6) tetralonyl, (7) benzosuberonyl, (8) indanolyl and (9) C6H5-CO-CH(CH3)-;
(c) a monovalent group derived from a cyclic amide compound;
(d) a lower alkyl; or
(e) a group of R21-CH=CH- in which R21 is hydrogen or a lower alkoxycarbonyl;
B is a bridging group;
T is a nitrogen;
Q is nitrogen, carbon or >N→0;
q is an integer of 1 to 3;
K is hydrogen, an optionally substituted phenyl group, an arylalkyl in which the phenyl may have a substituent, cynnamyl, a lower alkyl, pyridylmethyl, a cycloalkylalkyl, adamantanemethyl, furylmethyl, a cycloalkyl, a lower alkoxycarbonyl or an acyl; and
----¯ shows a single bond or a double bond.
The compound is useful for the preparation of pharmaceutical compositions and for medicaments effective against senile dementia.
一个环状胺化合物或其盐的定义公式为:其中J是(a) 选择自(1)
苯基,(2)
吡啶基,(3)
吡唑基,(4)
喹啉基,(5)
环己基,(6) 喹噁啉基和(7)
呋喃基的可选取代基;(b) 一价或二价基团,其中
苯基可以具有选自(1)
吲哚基,(2)
吲哚基
丙烷基,(3)
茚基,(4)
茚基
丙烷基,(5)
吲哚二
酮基,(6) 四
酮基,(7)
苯并戊二酰基,(8)
吲哚醇基和(9)
C6H5-CO-CH(
CH3)-的取代基;(c) 源自环状
酰胺化合物的一价基团;(d) 较低的烷基;或(e) R21-CH=CH-中R21是
氢或较低的烷
氧羰基的基团;B是桥接基团;T是
氮;Q是
氮、
碳或>N→0;q是1到3的整数;K是
氢、可选取代
苯基、芳基烷基,其中
苯基可以具有取代基,
肉桂酸基,较低的烷基,
吡啶甲基,环状烷基烷基,
金刚烷基
甲基,
呋喃基
甲基,环状烷基,较低的烷
氧羰基或酰基;而----¯表示单键或双键。该化合物用于制备药物组合物和用于治疗老年痴呆症的药物。